Health and Healthcare

Nektar Therapeutics : NKTR

All Nektar Therapeutics Articles

60 Articles

Chris Lange | Jan 18, 2020 at 8:45 AM EST

This Week’s Biggest Biotech Movers

This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of…

Chris Lange | Jan 15, 2020 at 1:06 PM EST

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.

Chris Lange | Nov 11, 2019 at 9:35 AM EST

Why This Early-Stage Autoimmune and Chronic Inflamatory Trial May Be a Big Hit

Nektar Therapeutics shares made a handy gain on Monday after the firm announced updated results from its first-in-human Phase 1a…

Jon C. Ogg | Oct 8, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Apollo, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target, TJX and More

Tuesday's top analyst upgrades, downgrades and initiations included Apollo Global Management, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target and TJX…

Jon C. Ogg | Aug 9, 2019 at 11:40 AM EDT

10 Stocks Getting Crushed After Earnings

These are not the only losers after earnings, but these are the big movers to the downside that also have…

Jon C. Ogg | Aug 9, 2019 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Activision Blizzard, ANGI, Azul, Baidu, CommScope, E*Trade, Kraft Heinz, Symantec, Uber and More

The top analyst upgrades, downgrades and initiations on Friday included Activision Blizzard, ANGI Home Services, Azul, Baidu, CommScope, E*Trade, Kraft…

Chris Lange | Jan 8, 2019 at 4:08 PM EST

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a positive day for the broad U.S. markets. All of the major exchanges had another solid performance, making…

Lee Jackson | Dec 13, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Arena Pharma, Autodesk, Coca-Cola, GE, Marvell, Monster Beverages, Nabors, Procter & Gamble and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Arena Pharmaceuticals, Autodesk, Coca-Cola, General Electric, Marvell, Monster Beverages,…

Chris Lange | Nov 12, 2018 at 4:08 PM EST

Monday’s Biggest Winners and Losers in the S&P 500

Monday was a down day for the broad U.S. markets. Each of the major exchanges started out the week on…

Chris Lange | Nov 6, 2018 at 4:02 PM EST

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a positive day for the broad U.S. markets. Although there seemed to be a lot of uncertainty leading…

Chris Lange | Nov 6, 2018 at 11:50 AM EST

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination…

Chris Lange | Oct 1, 2018 at 4:08 PM EDT

Monday’s Biggest Winners and Losers in the S&P 500

Monday was a mixed day for the broad U.S. markets. While all three major indices started out on a positive…

Chris Lange | Jun 4, 2018 at 10:45 AM EDT

Why Nektar Therapeutics Shares Are Tumbling

Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from…

Jon C. Ogg | Apr 17, 2018 at 7:40 AM EDT

Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates

Lung cancer may have just met a new standard of care. On top of that, it would be considered a new…

Lee Jackson | Feb 12, 2018 at 8:15 AM EST

Jefferies Has 4 Red-Hot Growth Stocks to Buy Despite Volatility

These four red-hot Jefferies growth stock picks could have substantial upside, especially if the market simmers down some.

1 2 3 4

Nektar Therapeutics : NKTR

All Nektar Therapeutics Articles

This Week’s Biggest Biotech Movers

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

Why This Early-Stage Autoimmune and Chronic Inflamatory Trial May Be a Big Hit

Top Analyst Upgrades and Downgrades: Apollo, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target, TJX and More

10 Stocks Getting Crushed After Earnings

Top Analyst Upgrades and Downgrades: Activision Blizzard, ANGI, Azul, Baidu, CommScope, E*Trade, Kraft Heinz, Symantec, Uber and More

Tuesday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Arena Pharma, Autodesk, Coca-Cola, GE, Marvell, Monster Beverages, Nabors, Procter & Gamble and More

Monday’s Biggest Winners and Losers in the S&P 500

Tuesday’s Biggest Winners and Losers in the S&P 500

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Monday’s Biggest Winners and Losers in the S&P 500

Why Nektar Therapeutics Shares Are Tumbling

Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates

Jefferies Has 4 Red-Hot Growth Stocks to Buy Despite Volatility

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

‘The Borrower Is Slave to the Lender’: Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

'The Borrower Is Slave to the Lender': Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

$1 Million in Retirement Savings Spends Like $40,000 a Year. Here's Why That's Not Enough.

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

Nektar Therapeutics : NKTR

All Nektar Therapeutics Articles

This Week’s Biggest Biotech Movers

Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock

Why This Early-Stage Autoimmune and Chronic Inflamatory Trial May Be a Big Hit

Top Analyst Upgrades and Downgrades: Apollo, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target, TJX and More

10 Stocks Getting Crushed After Earnings

Top Analyst Upgrades and Downgrades: Activision Blizzard, ANGI, Azul, Baidu, CommScope, E*Trade, Kraft Heinz, Symantec, Uber and More

Tuesday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Arena Pharma, Autodesk, Coca-Cola, GE, Marvell, Monster Beverages, Nabors, Procter & Gamble and More

Monday’s Biggest Winners and Losers in the S&P 500

Tuesday’s Biggest Winners and Losers in the S&P 500

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Monday’s Biggest Winners and Losers in the S&P 500

Why Nektar Therapeutics Shares Are Tumbling

Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates

Jefferies Has 4 Red-Hot Growth Stocks to Buy Despite Volatility

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

‘The Borrower Is Slave to the Lender’: Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

Featured Reads

'The Borrower Is Slave to the Lender': Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

$1 Million in Retirement Savings Spends Like $40,000 a Year. Here's Why That's Not Enough.